Successful octreotide treatment of chylous pleural effusion and lymphedema in the yellow nail syndrome [5]

Annals of Internal Medicine

Volumn 141, Issue 3, 2004, Pages 246-247

  Makrilakis, Konstantinos ^a   Pavlatos, Spyridon ^a   Giannikopoulos, Georgios ^a   Toubanakis, Christos ^a   Katsilambros, Nikolaos ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; OCTREOTIDE;

ADULT; CASE REPORT; CHYLE; CLINICAL FEATURE; HUMAN; LABORATORY TEST; LETTER; LONG TERM CARE; LYMPHEDEMA; MALE; PLEURA EFFUSION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; THORACOCENTESIS; TREATMENT OUTCOME; YELLOW NAIL SYNDROME;

EID: 3543131858     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-141-3-200408030-00028     Document Type: Letter

References (5)

1. Nordkild P, Kromann-Andersen H, Struve-Christensen E. Yellow nail syndrome-the triad of yellow nails, lymphedema and pleural effusions. A review of the literature and a case report. Acta Med Scand. 1986;219:221-7. [PMID: 3962735]
2. Widjaja A, Gratz KF, Ockenga J, Wagner S, Manns MP. Octreotide for therapy ofchylous ascites in yellow nail syndrome [Letter]. Gastroenterology. 1999;116:1017-8. [PMID: 10092335]
3. Rimensberger PC, Muller-Schenker B, Kalangos A, Beghetti M. Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg. 1998;66: 253-4. [PMID: 9692478]
4. Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ. Octreotide. N Engl J Med. 1996;334:246-54. [PMID: 8532003]
5. Sreedharan SP, Kodama KT, Peterson KE, Goetzl EJ. Distinct subsets of somatostatin receptors on cultured human lymphocytes. J Biol Chem. 1989;264:949-52. [PMID: 2562957]